Antibody response to Candida albicans cell wall antigens

FEMS Immunology and Medical Microbiology

Volumn 41, Issue 3, 2004, Pages 187-196

  López Ribot, José L ^a   Casanova, Manuel ^b   Murgui, Amelia ^b   Martínez, José P ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Candida albicans; Candidiasis; Cell wall; Immunodiagnostic; Protective antibodies; Serologic response; Vaccines

Indexed keywords

ADHESIN; ASPARTIC PROTEINASE; CELL ANTIBODY; CELL ANTIGEN; CELL MEMBRANE PROTEIN; FIBRINOGEN; GLYCOLYTIC ENZYME; GLYCOPROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; MANNOPROTEIN; MONOCLONAL ANTIBODY; OPSONIN; PROTEIN; VACCINE;

ANTIBODY RESPONSE; BINDING AFFINITY; CANDIDA ALBICANS; CANDIDIASIS; CARBOHYDRATE ANALYSIS; CELL COMPOSITION; CELL FUNCTION; CELL INTERACTION; CELL STRUCTURE; CELL WALL; FUNGAL CELL; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOLECULAR WEIGHT; MYCOSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SEROLOGY; SHORT SURVEY;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS; CELL WALL; HUMANS;

EID: 2942610587     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.03.012     Document Type: Short Survey

References (79)

1. Chaffin W.L., López-Ribot J.L., Casanova M., Gozalbo D., Martínez J.P. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:1998;130-180
2. Martínez J.P., Gil M.L., López-Ribot J.L., Chaffin W.L. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11:1998;121-141
3. Pfaller M.A., Jones R.N., Messer S.A., Edmond M.B., Wenzel R.P. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn. Microbiol. Infect. Dis. 30:1998;121-129
4. Deepe G.S. Jr. Prospects for the development of fungal vaccines. Clin. Microbiol. Rev. 10:1997;585-596
5. Calderone R.A., Braun P.C. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1991;1-20
6. Cassone A. Cell wall of Candida albicans: its functions and its impact on the host. McGinnis M.R., Borgers M. Current Topics in Medical Mycology. 1989;248-314 Springer Verlag, New York, Berlin
7. Domer J.E. Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit. Rev. Microbiol. 17:1989;33-51
8. Casadevall A. Antibody immunity and invasive fungal infections. Infect. Immunol. 63:1995;4211-4218
9. Casadevall A., Cassone A., Bistoni F., Cutler J.E., Magliani W., Murphy J.W., Polonelli L., Romani L. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36:1998;95-105
10. Levitz S.M. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14(Suppl 1):1992;S37-S42
11. De Bernardis F., Boccanera M., Adriani D., Spreghini E., Santoni G., Cassone A. Protective role of antimannan and anti-asparyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immunol. 65:1997;3399-3405
12. Han Y., Morrison R.P., Cutler J.E. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immunol. 66:1998;5771-5776
13. Han Y., Ulrich M.A., Cutler J.E. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179:1999;1477-1484
14. Matthews R., Burnie J. Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr. Opin. Investig. Drugs. 2:2001;472-476
15. Polonelli L., Casadevall A., Han Y., Bernardis F., Kirkland T.N., Matthews R.C., Adriani D., Boccanera M., Burnie J.P., Cassone A., Conti S., Cutler J.E., Frazzi R., Gregory C., Hodgetts S., Illidge C., Magliani W., Rigg G., Santoni G. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med. Mycol. 38(Suppl 1):2000;281-292
16. Romani L. Cytokine modulation of specific and nonspecific immunity to Candida albicans. Mycoses. 42(Suppl. 2):1999;45-48
17. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:1999;363-367
18. Bendel C.M., Hostetter M.K., McClellan M. Distinct mechanisms of epithelial adhesion for Candida albicans and Candida tropicalis: identification of the participating ligands and development of inhibitory peptides. J. Clin. Investig. 92:1993;1840-1849
19. Fidel P.L. Jr. Host defense against oropharyngcal and vaginal candidiasis: site-specific differences. Rev. Iberoam. Micol. 16:1999;8-15
20. Umazume M., Ueta E., Osaki T. Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy. J. Clin. Microbiol. 33:1995;432-439
21. Polonelli L., Seguy N., Conti S., Gerloni M., Bertolotti D., Cantelli C., Magliani W., Cailliez J.C. Monoclonal yeast killer toxin-like candidacidal antiidiotypic antibodies. Clin. Diagn. Lab. Immunol. 4:1997;142-146
22. Magliani W., Conti S., De Bernardis F., Gerloni M., Bertolotti D., Mozzoni P., Cassone A., Polonelli L. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 1:1997;155-158
23. Naglik J.R., Challacombe S.J., Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol. Mol. Biol. Rev. 67:2003;400-428
24. Han Y., Morrison R.P., Cutler J.E. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immunol. 66:1998;5771-5776
25. Han Y., Ulrich M.A., Cutler J.E. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179:1999;1477-1484
26. De Bernardis F., Santoni G., Boccanera M., Spreghini E., Adriana D., Morelli L., Cassone A. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect. Immunol. 68:2000;3297-3304
27. Moragues M.D., Omaetxebarria M.J., Elguezabal N., Sevilla M.J., Conti S., Polonelli L., Pontón J. A monoclonal abtibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immunol. 71:2003;5273-5279
28. Matthews R.C., Burnie J.P. Antibodies against Candida: potential therapeutics? Trends Microbiol. 4:1996;354-358
29. Matthews R., Burnie J. Antifungal antibodies: a new approach to the treatment of systemic candidiasis. Curr. Opin. Investig. Drugs. 2:2001;472-476
30. Dixon D.M., Casadevall A., Klein B., Mendoza L., Travassos L., Deepe G.S. Jr. Development of vaccines and their use in the prevention of fungal infections. Med. Mycol. 36(Suppl 1):1998;57-67
31. Matthews R.C. Pathogenicity determinants of Candida albicans: potential targets for immunotherapy? Microbiology. 140:1994;1505-1511
32. Hube B. Extracellular proteinases of human pathogenic fungi. Ernst J.F., Schmidt A. Contribution to Microbiology. Dimorphism in Human Pathogenic and Apathogenic Yeasts. 2000;126-137 S. Karger AG, Basel, Switzerland
33. Ghannoum M.A. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:2000;122-143
34. Hube B., Naglik J.R. Extracellular hydrolases. Calderone R.A. Candida and Candidiasis. 2002;107-122 ASM Press, Washington, DC
35. Ghadjari A., Matthews R.C., Burnie J.P. Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol. Med. Microbiol. 19:1997;115-123
36. López-Ribot J.L., Sepúlveda P., Cervera A.M., Roig P., Gozalbo D., Martínez J.P. Cloning of a cDNA fragment encoding part of the protein moiety of the 58-kDa fibrinogen-binding mannoprotein of Candida albicans. FEMS Microbiol. Lett. 157:1997;273-278
37. Sentandreu M., Elorza M.V., Sentandreu R., Fonzi W.A. Cloning and characterization of PRAI, a gene encoding a novel pH-regulated antigen of Candida albicans. J. Bacteriol. 180:1998;282-289
38. Viudes A., Perea S., López-Ribot J.L. Identification of continuous B-cell epitopes on the protein moiety of the 58-kilodalton cell wall mannoprotein of Candida albicans belonging to a familiy of immunodominant fungal antigens. Infect. Immunol. 69:2001;2909-2919
39. Sepúlveda P., López-Ribot J.L., Murgui A., Canton E., Navarro D., Martínez J.P. Candida albicans fibrinogen binding protein: expression in clinical strains and immunogcnicity in patients with systemic candidiasis. Int. Microbiol. 1:1998;209-216
40. Kauffmann S.H.E. Heat shock proteins and the immune response. Immunol. Today. 11:1990;129-136
41. Matthews R.C., Burnie J.P. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for circulating immunodominant 47-kilodalton antigen. J. Clin. Microbiol. 26:1988;459-463
42. Burt E.T., Daly R., Hoganson D., Tsirulnikov Y., Essmann M., Larsen B. Isolation and partial characterization of Hsp90 from Candida albicans. Ann. Clin. Lab. Sci. 33:2003;86-93
43. Matthews R.C., Burnie J.P., Howat D., Rowland T., Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology. 74:1991;20-24
44. Matthews R.C., Hodgetts S., Burnie J.P. Preliminary assessment of a human recombinant antibody to Hsp90 in the treatment of murine invasive candidiasis. J. Infect. Dis. 171:1995;1668-1671
45. Matthews R., Burnie J.P., Lee W. The application of epitope mapping in the development of a new serological test for systemic candidiasis. J. Immunol. Methods. 143:1991;73-79
46. Burnie J.P., Matthews R.C., Tabaqchali S. Developments in the serological diagnosis of opportunistc fungal infections. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and caracterization of serological response to Candida albicans. J. Antimicrob. Chemother. 28:1991;23-33
47. Matthews R.C., Rigg G., Hodgetts S., Carter T., Chapman C., Gregory C., Illidge C., Burnie J. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal Hsp90. Antimicrob. Agents Chemother. 47:2003;2208-2216
48. Cho T., Toyoda M., Sudoh M., Nakashima Y., Calderone R.A., Kaminishi H. Isolation and sequencing of the Candida albicans MSI3, a putative novel member of the Hsp70 family. Yeast. 2003;20, 149-156
49. Li X.S., Reddy M.S., Baev D., Edgerton M. Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5. J. Biol. Chem. 278:2003;28553-28561
50. Pitarch A., Díez-Orejas R., Molero G., Pardo M., Sanchez M., Gil C., Nombela C. Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics. 1:2001;550-559
51. Bromuro C., La Valle R., Sandini S., Urbani F., Ausiello C.M., Morelli L., Fe d'Ostiani C., Romani L., Cassone A. A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis. Infect. Immunol. 66:1998;2154-2162
52. Pitarch A., Sánchez M., Nombela C., Gil C. Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol. Cell. Proteomics. 1:2002;967-982
53. Walsh T.J., Hathorn J.W., Sobel J.D., Merz W.G., Sánchez V., Maret S.M., Buckley H.R., Pfaller M.A., Schaufele R., Silva C., Navarro E., Lecciones L., Chandraseka P., Lee J., Pizzo P.A. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324:1991;1026-1031
54. Bromuro C., Torosantucci A., Chiani P., Conti S., Polonelli L., Cassone A. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immunol. 70:2002;5462-5470
55. Guyard C., Dehecq E., Tissier J.P., Polonelli L., Dei-Cas E., Cailliez J.C., Menozzi F.D. Involvement of β-glucan in the wide spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin. Mol. Med. 8:2002;686-694
56. Guyard C., Sèguy N., Cailliez J.C., Drobecq H., Polonelli L., Dei-Cas E., Mercenier A., Menozzi F.D. Characterization of a Williopsis saturnus var. mrakii high molecular weight secreted killer toxin with broad-spectrum antimicrobial activity. J. Antimicrob. Chemother. 49:2002;961-971
57. Polonelli L., Magliani W., Conti S., Bracci L., Lozzi L., Neri P., Adriani D., De Bernardis F., Cassone A. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis. Infect. Immunol. 71:2003;6205-6212
58. Cassone A., Conti S., De Bernardis F., Polonelli L. Antibodies, killer toxin and antifungal immunoprotection: a lesson from nature? Immunol. Today. 18:1997;164-169
59. Kanbe T., Cutler J.E. Minimum chemical requirements for adhesin activity of the acid-stable part of Candida albicans cell wall phosphomannoprotein complex. Infect. Immunol. 66:1998;5812-5818
60. Han Y., Kanbe T., Cherniak R., Cutler J.E. Biochemical characterization of Candida albicans epitopes that can elicit protective and non-protective antibodies. Infect. Immunol. 65:1997;4100-4107
61. Trinel P.A., Faille C., Jacquinot P.M., Caillez J.C., Poulain D. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect. Immunol. 60:1992;3845-3851
62. Trinel P.A., Borg-von-Zepelin M., Lepage G., Jouault T., Mackenzie D., Poulain D. Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigen as a phospholipomannan containing β-1, 2-linked oligomannosides. Infect. Immunol. 61:1993;4398-4405
63. Han Y., Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immunol. 63:1995;2714-2719
64. Jones J.M. Laboratory diagnosis of invasive candidiasis. Clin. Microbiol. Rev. 3:1990;32-45
65. Wiesmuller K.H., Fleckenstein B., Jung G. Peptide vaccines and peptide libraries. Biol. Chem. 382:2001;571-579
66. Zauner W., Lingnau K., Mattner F., von Gabain A., Buschle M. Defined synthetic vaccines. Biol.Chem. 382:2001;581-595
67. Cárdenas-Freytag L., Cheng E., Mayeux P., Domer J.E., Clements J.D. Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis. Infect. Immunol. 67:1999;826-833
68. Mizutani S., Endo M., Ino-Ue T., Kurasawa M., Uno Y., Saito H., Kato I., Takesako K. Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections. Antimicrob. Agents Chemother. 44:2000;243-247
69. Tavares D., Ferreira P., Vilanova M., Videira A., Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int. Immunol. 7:1995;785-796
70. Reiss E., Morrison C. Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev. 6:1993;311-323
71. Pontón J., Moragues M.D., Quindós G. Non-culture-based diagnostics. Calderone R.A. Candida and Candidiasis. 2002;395-425 ASM Press, Washington, DC
72. Sendid B., Tabouret M., Poirot J.L., Mathieu D., Fruit J., Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J. Clin. Microbiol. 37:1999;1510-1517
73. Sendid B., Poirot J.L., Tabouret M., Bonnin A., Caillot D., Camus D., Poulain D. Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J. Med. Microbiol. 51:2002;433-442
74. Sendid B., Caillot D., Baccouch-Humbert B., Klingspor L., Grandjean M., Bonnin A., Poulain D. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J. Clin. Microbiol. 41:2003;4551-4558
75. Gentry L.O., Wilkinson I.D., Lea A.S., Price M.F. Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur. J. Clin. Microbiol. 2:1983;122-128
76. De Repentigny L., Reiss E. Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev. Infect. Dis. 6:1984;301-312
77. Herent P., Stynen D., Hernando F., Fruit J., Poulain D. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis. J. Clin. Microbiol. 30:1992;2158-2164
78. Gutiérrez J., Maroto C., Piédrola G., Martín E., Pérez J.A. Circulating Candida antigens and antibodies: useful markers of candidemia. J. Clin. Microbiol. 31:1993;2550-2552
79. Gutiérrez J., Liébana J. Immunological methods for the detection of structural components and metabolites of bacteria and fungi in blood. Clinical effectiveness. Ann. Biol. Clin. 51:1993;83-90